Total : 15 View more »
Clinical Data, Inc. (NASDAQ: CLDA) today announced that it intends to offer shares of common stock in an underwritten public offering. Piper Jaffray & Co. is acting as the sole book running manager, with Wedbush PacGrow Life Sciences, Roth Capita
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9456
NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at the Eleventh Annual Rodman & Renshaw Healthcare Conference. Clinical Data's presentation will take place at 2:50
http://www.biospace.com/news_story.aspx?StoryID=154902&full=1
Clinical Data licensed its preclinical candidate for B-cell cancers to CombinatoRx in a deal worth up to $252 million. CombinatoRx will initially develop this adenosine A2A The $25
PR: M2S, Inc. and the Vascular Study Group of New England (VSGNE) have partnered to advance the VSGNE quality improvement registry. Clinical Data Pathways, powered by M2S, is a secure, web-based clinical data management solution that offers physicians, hospitals, medical centers and clinical
http://www.prweb.com/releases/medical/imaging/prweb3074594.htm
Total : 47 View more »
Nov 03, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Clinical Data (NASDAQ:CLDA) on October 28, 2009 at $16.59.
Since then, Clinical Data has returned 8.1% as of today's recent price of $15.24. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Nov 03, 2009 (Wall Street Horizon via COMTEX) --
Clinical Data, Inc. (CLDA)
Expected next earnings release: Announcement date: 11/9/2009 - Before Market Earnings Quarter: Q2 Announcement Status: Unconfirmed
ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed an extension to its strategic agreement with Eli Lilly and Company (NYSE:LLY) to manage the company's clinical data...
Nov 02, 2009 (Wall Street Horizon via COMTEX) --
Clinical Data, Inc. (CLDA)
Expected next earnings release: Announcement date: 11/9/2009 - Before Market Earnings Quarter: Q2 Announcement Status: Unconfirmed
Total : 450 View more »
Health, ... M2S Inc. and the Vascular Study Group of New England (VSGNE) have ...West Lebanon NH (PRWEB) October 20 2009 -- M2S Inc. and the Vascula...,Vascular,Study,Group,of,New,England,Selects,Clinical,Data,Pathways,,Powered,by,M2S,,as,Quality,Improvement,Registry,Provider,medicine,medical news
Overview Avalon Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of first-in-class cancer therapeutics. Our lead product candidate, AVN944, an IMPDH inhibitor, is in Phase II clinical development.
Real-world examples in data interpretation prepare readers for the OSCE paper in the primary exam, and for the structured vivas in the final exam for the Fellowship of the Royal College of Anaesthetists.
http://www.elsevier.com/wps/find/bookdescription.cws_home/694597/description?navopenmenu=-2
By Fain Hughes, fhughes@knobias.com Clinical Data, Inc. (CLDA) announced a collaboration and licensing agreement with CombinatoRx, Inc. (CRXX) to develop an adenosine A2A agonist compound in a combination therapy for the treatment of multiple myeloma, and other B-cell cancers. Under the agreement,
Total : 55 View more »
Stay informed on the latest Clinical Data Incorporated news. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
http://www.thestreet.com/topic/6128/clinical-data-incorporated.html
Information about Clinical Data Incorporated ... RSS feeds allow Web site content to be gathered via feed reader software.
http://www.courant.com/topic/economy-business-finance/clinical-data-incorporated-ORCRP003428.topic
Find business news, business blogs, executive career advice, business travel, business culture, company & executive profiles.
http://www.portfolio.com/resources/company-profiles/Clinical-Data-Incorporated-997
Get the latest CLDA - Clinical Data Incorporated stock market performance data. TheStreet is the source for financial market news, trading stock, quotes, and personal finance ...
Job details for a Contract Clinical Data Manager job in South East listed at Totaljobs.com - 45762331
http://www.totaljobs.com/JobSeeking/Contract-Clinical-Data-Manager_job45762331
Lead Clinical Data Managers - West London - Pharmaceutical CompanyA major Pharmaceutical Company based in West London requires innovative Lead Data Manager
At Covance, your imagination, your dedication, and your drive to find solutions to challenging projects begin on your very first day. Covance is one of the
http://www.newscientistjobs.com/jobs/job/clinical-data-manager-1-united-states-200628696.htm
Senior Clinical Data Analyst Senior Clinical Data Analyst Salary:- £23-27k + BenefitsLocation:- Yorkshire (can be home based for 4 days a week
http://www.newscientistjobs.com/jobs/job/senior-clinical-data-analyst-yorkshire-200629267.htm
Health,...Featured June 11-12 at the 5th Annual Games for Health Conference ...PORTLAND Maine May 18 -- The Games for Healt... ...,Games,for,Health,Conference,Announces,First,Cognitive,Health,Track,Powered,by,SharpBrains,medicine,medical news today,latest medical news,medical newsletters,current
CRIS—the NIH Clinical Research Information System—is a $60 million project that will tie together and support patient care, research and management at the Clinical Center and the Mark O. Hatfield Clinical Research Center.
Health, Wednesday May 6 2009 ... ...CALGARY April 29 / NUCRYST Pharmaceuticals Cor...The briefing via conference call is set for 9:00 a.m. EDT. To partic...The briefing will be recorded and available for re-broadcast on